Global and China CD38 Monoclonal Antibody Drugs Market Insights, Forecast to 2027

Global and China CD38 Monoclonal Antibody Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 CD38 Monoclonal Antibody Drugs Product Introduction
1.2 Market by Type
1.2.1 Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Type
1.2.2 Daretuzumab
1.2.3 Isartuximab
1.2.4 Engineered Toxin Body
1.3 Market by Application
1.3.1 Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Application
1.3.2 Multiple Myeloma
1.3.3 Diffuse Large B Cell Lymphoma
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global CD38 Monoclonal Antibody Drugs Market Size, Estimates and Forecasts
2.1.1 Global CD38 Monoclonal Antibody Drugs Revenue 2016-2027
2.1.2 Global CD38 Monoclonal Antibody Drugs Sales 2016-2027
2.2 Global CD38 Monoclonal Antibody Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 CD38 Monoclonal Antibody Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global CD38 Monoclonal Antibody Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global CD38 Monoclonal Antibody Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 CD38 Monoclonal Antibody Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global CD38 Monoclonal Antibody Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global CD38 Monoclonal Antibody Drugs Revenue Forecast by Region (2022-2027)
3 Global CD38 Monoclonal Antibody Drugs Competitor Landscape by Players
3.1 Global Top CD38 Monoclonal Antibody Drugs Manufacturers by Sales
3.1.1 Global CD38 Monoclonal Antibody Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global CD38 Monoclonal Antibody Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top CD38 Monoclonal Antibody Drugs Manufacturers by Revenue
3.2.1 Key CD38 Monoclonal Antibody Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global CD38 Monoclonal Antibody Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global CD38 Monoclonal Antibody Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global CD38 Monoclonal Antibody Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by CD38 Monoclonal Antibody Drugs Revenue in 2020
3.2.6 Global CD38 Monoclonal Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global CD38 Monoclonal Antibody Drugs Price by Manufacturers
3.4 Global CD38 Monoclonal Antibody Drugs Manufacturing Base Distribution, Product Types
3.4.1 CD38 Monoclonal Antibody Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers CD38 Monoclonal Antibody Drugs Product Type
3.4.3 Date of International Manufacturers Enter into CD38 Monoclonal Antibody Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global CD38 Monoclonal Antibody Drugs Market Size by Type (2016-2021)
4.1.1 Global CD38 Monoclonal Antibody Drugs Sales by Type (2016-2021)
4.1.2 Global CD38 Monoclonal Antibody Drugs Revenue by Type (2016-2021)
4.1.3 CD38 Monoclonal Antibody Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global CD38 Monoclonal Antibody Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global CD38 Monoclonal Antibody Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global CD38 Monoclonal Antibody Drugs Revenue Forecast by Type (2022-2027)
4.2.3 CD38 Monoclonal Antibody Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global CD38 Monoclonal Antibody Drugs Market Size by Application (2016-2021)
5.1.1 Global CD38 Monoclonal Antibody Drugs Sales by Application (2016-2021)
5.1.2 Global CD38 Monoclonal Antibody Drugs Revenue by Application (2016-2021)
5.1.3 CD38 Monoclonal Antibody Drugs Price by Application (2016-2021)
5.2 CD38 Monoclonal Antibody Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global CD38 Monoclonal Antibody Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global CD38 Monoclonal Antibody Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global CD38 Monoclonal Antibody Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China CD38 Monoclonal Antibody Drugs Market Size YoY Growth 2016-2027
6.1.1 China CD38 Monoclonal Antibody Drugs Sales YoY Growth 2016-2027
6.1.2 China CD38 Monoclonal Antibody Drugs Revenue YoY Growth 2016-2027
6.1.3 China CD38 Monoclonal Antibody Drugs Market Share in Global Market 2016-2027
6.2 China CD38 Monoclonal Antibody Drugs Market Size by Players (International and Local Players)
6.2.1 China Top CD38 Monoclonal Antibody Drugs Players by Sales (2016-2021)
6.2.2 China Top CD38 Monoclonal Antibody Drugs Players by Revenue (2016-2021)
6.3 China CD38 Monoclonal Antibody Drugs Historic Market Review by Type (2016-2021)
6.3.1 China CD38 Monoclonal Antibody Drugs Sales Market Share by Type (2016-2021)
6.3.2 China CD38 Monoclonal Antibody Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China CD38 Monoclonal Antibody Drugs Price by Type (2016-2021)
6.4 China CD38 Monoclonal Antibody Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China CD38 Monoclonal Antibody Drugs Sales Forecast by Type (2022-2027)
6.4.2 China CD38 Monoclonal Antibody Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China CD38 Monoclonal Antibody Drugs Price Forecast by Type (2022-2027)
6.5 China CD38 Monoclonal Antibody Drugs Historic Market Review by Application (2016-2021)
6.5.1 China CD38 Monoclonal Antibody Drugs Sales Market Share by Application (2016-2021)
6.5.2 China CD38 Monoclonal Antibody Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China CD38 Monoclonal Antibody Drugs Price by Application (2016-2021)
6.6 China CD38 Monoclonal Antibody Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China CD38 Monoclonal Antibody Drugs Sales Forecast by Application (2022-2027)
6.6.2 China CD38 Monoclonal Antibody Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China CD38 Monoclonal Antibody Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America CD38 Monoclonal Antibody Drugs Market Size YoY Growth 2016-2027
7.2 North America CD38 Monoclonal Antibody Drugs Market Facts & Figures by Country
7.2.1 North America CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021)
7.2.2 North America CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific CD38 Monoclonal Antibody Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific CD38 Monoclonal Antibody Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe CD38 Monoclonal Antibody Drugs Market Size YoY Growth 2016-2027
9.2 Europe CD38 Monoclonal Antibody Drugs Market Facts & Figures by Country
9.2.1 Europe CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021)
9.2.2 Europe CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America CD38 Monoclonal Antibody Drugs Market Size YoY Growth 2016-2027
10.2 Latin America CD38 Monoclonal Antibody Drugs Market Facts & Figures by Country
10.2.1 Latin America CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021)
10.2.2 Latin America CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa CD38 Monoclonal Antibody Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa CD38 Monoclonal Antibody Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Johnson
12.1.1 Johnson Corporation Information
12.1.2 Johnson Description and Business Overview
12.1.3 Johnson CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Johnson CD38 Monoclonal Antibody Drugs Products Offered
12.1.5 Johnson Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Description and Business Overview
12.2.3 Sanofi CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi CD38 Monoclonal Antibody Drugs Products Offered
12.2.5 Sanofi Recent Development
12.3 Takeda Pharmaceutical Company
12.3.1 Takeda Pharmaceutical Company Corporation Information
12.3.2 Takeda Pharmaceutical Company Description and Business Overview
12.3.3 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Products Offered
12.3.5 Takeda Pharmaceutical Company Recent Development
12.4 CASI Pharmaceutical Company
12.4.1 CASI Pharmaceutical Company Corporation Information
12.4.2 CASI Pharmaceutical Company Description and Business Overview
12.4.3 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Products Offered
12.4.5 CASI Pharmaceutical Company Recent Development
12.5 Mab Biopharma
12.5.1 Mab Biopharma Corporation Information
12.5.2 Mab Biopharma Description and Business Overview
12.5.3 Mab Biopharma CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mab Biopharma CD38 Monoclonal Antibody Drugs Products Offered
12.5.5 Mab Biopharma Recent Development
12.11 Johnson
12.11.1 Johnson Corporation Information
12.11.2 Johnson Description and Business Overview
12.11.3 Johnson CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Johnson CD38 Monoclonal Antibody Drugs Products Offered
12.11.5 Johnson Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 CD38 Monoclonal Antibody Drugs Industry Trends
13.2 CD38 Monoclonal Antibody Drugs Market Drivers
13.3 CD38 Monoclonal Antibody Drugs Market Challenges
13.4 CD38 Monoclonal Antibody Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 CD38 Monoclonal Antibody Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Daretuzumab
Table 3. Major Manufacturers of Isartuximab
Table 4. Major Manufacturers of Engineered Toxin Body
Table 5. Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Application (2021-2027) & (KG)
Table 6. Global CD38 Monoclonal Antibody Drugs Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global CD38 Monoclonal Antibody Drugs Sales by Regions (2016-2021) & (KG)
Table 8. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Regions (2016-2021)
Table 9. Global CD38 Monoclonal Antibody Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global CD38 Monoclonal Antibody Drugs Sales Forecast by Region (2022-2027) & (KG)
Table 11. Global CD38 Monoclonal Antibody Drugs Sales Market Share Forecast by Region (2022-2027)
Table 12. Global CD38 Monoclonal Antibody Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global CD38 Monoclonal Antibody Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global CD38 Monoclonal Antibody Drugs Sales by Manufacturers (2016-2021) (KG)
Table 15. Global CD38 Monoclonal Antibody Drugs Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top CD38 Monoclonal Antibody Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 17. CD38 Monoclonal Antibody Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. CD38 Monoclonal Antibody Drugs Revenue Share by Manufacturers (2016-2021)
Table 19. Global CD38 Monoclonal Antibody Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global CD38 Monoclonal Antibody Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD38 Monoclonal Antibody Drugs as of 2020)
Table 21. Key Manufacturers CD38 Monoclonal Antibody Drugs Price (2016-2021) (US$/g)
Table 22. CD38 Monoclonal Antibody Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers CD38 Monoclonal Antibody Drugs Product Type
Table 24. Date of International Manufacturers Enter into CD38 Monoclonal Antibody Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global CD38 Monoclonal Antibody Drugs Sales by Type (2016-2021) (KG)
Table 27. Global CD38 Monoclonal Antibody Drugs Sales Share by Type (2016-2021)
Table 28. Global CD38 Monoclonal Antibody Drugs Revenue by Type (2016-2021) (US$ Million)
Table 29. Global CD38 Monoclonal Antibody Drugs Revenue Share by Type (2016-2021)
Table 30. CD38 Monoclonal Antibody Drugs Average Selling Price (ASP) by Type (2016-2021) & (US$/g)
Table 31. Global CD38 Monoclonal Antibody Drugs Sales Forecast by Type (2022-2027) & (KG)
Table 32. Global CD38 Monoclonal Antibody Drugs Sales Market Share Forecast by Type (2022-2027)
Table 33. Global CD38 Monoclonal Antibody Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global CD38 Monoclonal Antibody Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global CD38 Monoclonal Antibody Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/g)
Table 36. Global CD38 Monoclonal Antibody Drugs Sales by Application (2016-2021) (KG)
Table 37. Global CD38 Monoclonal Antibody Drugs Sales Share by Application (2016-2021)
Table 38. Global CD38 Monoclonal Antibody Drugs Revenue by Application (2016-2021) (US$ Million)
Table 39. Global CD38 Monoclonal Antibody Drugs Revenue Share by Application (2016-2021)
Table 40. CD38 Monoclonal Antibody Drugs Average Selling Price (ASP) by Application (2016-2021) & (US$/g)
Table 41. Global CD38 Monoclonal Antibody Drugs Sales Forecast by Application (2022-2027) & (KG)
Table 42. Global CD38 Monoclonal Antibody Drugs Sales Market Share Forecast by Application (2022-2027)
Table 43. Global CD38 Monoclonal Antibody Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global CD38 Monoclonal Antibody Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global CD38 Monoclonal Antibody Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/g)
Table 46. China CD38 Monoclonal Antibody Drugs Sales (KG) of Key Companies (2016-2021)
Table 47. China CD38 Monoclonal Antibody Drugs Sales Share by Company (2016-2021)
Table 48. China CD38 Monoclonal Antibody Drugs Revenue (US$ Million) by Company (2016-2021)
Table 49. China CD38 Monoclonal Antibody Drugs Revenue Share by Company (2016-2021)
Table 50. China CD38 Monoclonal Antibody Drugs Sales (KG) by Type (2016-2021)
Table 51. China CD38 Monoclonal Antibody Drugs Sales Share by Type (2016-2021)
Table 52. China CD38 Monoclonal Antibody Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China CD38 Monoclonal Antibody Drugs Price (US$/g) by Type (2016-2021)
Table 54. China CD38 Monoclonal Antibody Drugs Sales (KG) by Type (2022-2027)
Table 55. China CD38 Monoclonal Antibody Drugs Sales Share by Type (2022-2027)
Table 56. China CD38 Monoclonal Antibody Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China CD38 Monoclonal Antibody Drugs Revenue Share by Type (2022-2027)
Table 58. China CD38 Monoclonal Antibody Drugs Price (US$/g) by Type (2022-2027)
Table 59. China CD38 Monoclonal Antibody Drugs Sales (KG) by Application (2016-2021)
Table 60. China CD38 Monoclonal Antibody Drugs Sales Share by Application (2016-2021)
Table 61. China CD38 Monoclonal Antibody Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China CD38 Monoclonal Antibody Drugs Price (US$/g) by Application (2016-2021)
Table 63. China CD38 Monoclonal Antibody Drugs Sales (KG) by Application (2022-2027)
Table 64. China CD38 Monoclonal Antibody Drugs Sales Share by Application (2022-2027)
Table 65. China CD38 Monoclonal Antibody Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China CD38 Monoclonal Antibody Drugs Revenue Share by Application (2022-2027)
Table 67. China CD38 Monoclonal Antibody Drugs Price (US$/g) by Application (2022-2027)
Table 68. North America CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021) & (KG)
Table 69. North America CD38 Monoclonal Antibody Drugs Sales Market Share by Country (2016-2021)
Table 70. North America CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America CD38 Monoclonal Antibody Drugs Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Region (2016-2021) & (KG)
Table 73. Asia Pacific CD38 Monoclonal Antibody Drugs Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue Market Share by Region (2016-2021)
Table 76. Europe CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021) & (KG)
Table 77. Europe CD38 Monoclonal Antibody Drugs Sales Market Share by Country (2016-2021)
Table 78. Europe CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe CD38 Monoclonal Antibody Drugs Revenue Market Share by Country (2016-2021)
Table 80. Latin America CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021) & (KG)
Table 81. Latin America CD38 Monoclonal Antibody Drugs Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America CD38 Monoclonal Antibody Drugs Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Country (2016-2021) & (KG)
Table 85. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue Market Share by Country (2016-2021)
Table 88. Johnson Corporation Information
Table 89. Johnson Description and Business Overview
Table 90. Johnson CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 91. Johnson CD38 Monoclonal Antibody Drugs Product
Table 92. Johnson Recent Development
Table 93. Sanofi Corporation Information
Table 94. Sanofi Description and Business Overview
Table 95. Sanofi CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 96. Sanofi Product
Table 97. Sanofi Recent Development
Table 98. Takeda Pharmaceutical Company Corporation Information
Table 99. Takeda Pharmaceutical Company Description and Business Overview
Table 100. Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 101. Takeda Pharmaceutical Company Product
Table 102. Takeda Pharmaceutical Company Recent Development
Table 103. CASI Pharmaceutical Company Corporation Information
Table 104. CASI Pharmaceutical Company Description and Business Overview
Table 105. CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 106. CASI Pharmaceutical Company Product
Table 107. CASI Pharmaceutical Company Recent Development
Table 108. Mab Biopharma Corporation Information
Table 109. Mab Biopharma Description and Business Overview
Table 110. Mab Biopharma CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 111. Mab Biopharma Product
Table 112. Mab Biopharma Recent Development
Table 113. CD38 Monoclonal Antibody Drugs Market Trends
Table 114. CD38 Monoclonal Antibody Drugs Market Drivers
Table 115. CD38 Monoclonal Antibody Drugs Market Challenges
Table 116. CD38 Monoclonal Antibody Drugs Market Restraints
Table 117. CD38 Monoclonal Antibody Drugs Customers List
Table 118. CD38 Monoclonal Antibody Drugs Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. CD38 Monoclonal Antibody Drugs Product Picture
Figure 2. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Daretuzumab Product Picture
Figure 4. Isartuximab Product Picture
Figure 5. Engineered Toxin Body Product Picture
Figure 6. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Application in 2020 & 2027
Figure 7. Multiple Myeloma
Figure 8. Diffuse Large B Cell Lymphoma
Figure 9. Other
Figure 10. CD38 Monoclonal Antibody Drugs Report Years Considered
Figure 11. Global CD38 Monoclonal Antibody Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global CD38 Monoclonal Antibody Drugs Market Size 2016-2027 (US$ Million)
Figure 13. Global CD38 Monoclonal Antibody Drugs Sales 2016-2027 (KG)
Figure 14. Global CD38 Monoclonal Antibody Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Region (2016-2021)
Figure 16. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Region in 2020
Figure 17. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Region (2016-2021)
Figure 18. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Region in 2020
Figure 19. Global CD38 Monoclonal Antibody Drugs Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by CD38 Monoclonal Antibody Drugs Revenue in 2020
Figure 21. CD38 Monoclonal Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Type (2016-2021)
Figure 23. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Type in 2020
Figure 24. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Type (2016-2021)
Figure 25. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Type in 2020
Figure 26. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Application (2016-2021)
Figure 27. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Application in 2020
Figure 28. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Application (2016-2021)
Figure 29. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Application in 2020
Figure 30. China CD38 Monoclonal Antibody Drugs Sales Growth Rate 2016-2027 (KG)
Figure 31. China CD38 Monoclonal Antibody Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China CD38 Monoclonal Antibody Drugs Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest CD38 Monoclonal Antibody Drugs Players Market Share by Revenue in CD38 Monoclonal Antibody Drugs in 2020
Figure 34. China CD38 Monoclonal Antibody Drugs Revenue Share by Type (2016-2021)
Figure 35. China CD38 Monoclonal Antibody Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China CD38 Monoclonal Antibody Drugs Revenue Share by Application (2016-2021)
Figure 37. China CD38 Monoclonal Antibody Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America CD38 Monoclonal Antibody Drugs Sales Growth Rate 2016-2021 (KG)
Figure 39. North America CD38 Monoclonal Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America CD38 Monoclonal Antibody Drugs Sales Market Share by Country in 2020
Figure 41. North America CD38 Monoclonal Antibody Drugs Revenue Market Share by Country in 2020
Figure 42. United States CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 43. United States CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 45. Canada CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe CD38 Monoclonal Antibody Drugs Sales Growth Rate 2016-2021 (KG)
Figure 47. Europe CD38 Monoclonal Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe CD38 Monoclonal Antibody Drugs Sales Market Share by Country in 2020
Figure 49. Europe CD38 Monoclonal Antibody Drugs Revenue Market Share by Country in 2020
Figure 50. Germany CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 51. Germany CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 53. France CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 55. U.K. CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 57. Italy CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 59. Russia CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific CD38 Monoclonal Antibody Drugs Sales Growth Rate 2016-2021 (KG)
Figure 61. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific CD38 Monoclonal Antibody Drugs Sales Market Share by Region in 2020
Figure 63. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue Market Share by Region in 2020
Figure 64. China CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 65. China CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 67. Japan CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 69. South Korea CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 71. India CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 73. Australia CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. China Taiwan CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 75. China Taiwan CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 77. Indonesia CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 79. Thailand CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 81. Malaysia CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Latin America CD38 Monoclonal Antibody Drugs Sales Growth Rate 2016-2021 (KG)
Figure 83. Latin America CD38 Monoclonal Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 84. Latin America CD38 Monoclonal Antibody Drugs Sales Market Share by Country in 2020
Figure 85. Latin America CD38 Monoclonal Antibody Drugs Revenue Market Share by Country in 2020
Figure 86. Mexico CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 87. Mexico CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Brazil CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 89. Brazil CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Argentina CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 91. Argentina CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales Growth Rate 2016-2021 (KG)
Figure 93. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 94. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales Market Share by Country in 2020
Figure 95. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue Market Share by Country in 2020
Figure 96. Turkey CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 97. Turkey CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Saudi Arabia CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 99. Saudi Arabia CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. UAE CD38 Monoclonal Antibody Drugs Sales Growth Rate (2016-2021) (KG)
Figure 101. UAE CD38 Monoclonal Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. CD38 Monoclonal Antibody Drugs Value Chain
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs